During the past decade, Adana Baskent University Hospital; Medical Oncology conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adana Baskent University Hospital; Medical Oncology" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "European Society for Blood and Marrow Transplantation" with 1 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adana Baskent University Hospital; Medical Oncology" #1 collaborator was "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator, "European Myeloma Network" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Adana Baskent University Hospital; Medical Oncology" are "Breast Cancer" (3 trials), "Myelofibrosis" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (2 trials), "Ovarian Cancer" (2 trials) and "Post Essential Thrombocythemia Myelofibrosis" (2 trials). Many other conditions were trialed in "Adana Baskent University Hospital; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Adana Baskent University Hospital; Medical Oncology" are "Drug" (25 trials), "Device" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (9 trials), "Placebo" (5 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Tiragolumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Adana Baskent University Hospital; Medical Oncology" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Adana Baskent University Hospital; Medical Oncology". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Adana Baskent University Hospital; Medical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Adana Baskent University Hospital; Medical Oncology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Adana Baskent University Hospital; Medical Oncology has several departments that took part in Clinical trials: "Ankara Baskent University Medical Faculty; Department of Ophthalmology" - 5 trials, "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü" - 2 trials